SNRPGP14

Across TCGA pan-cancer cohorts, SNRPGP14 RNA differs between tumor and matched normal tissue in 8 of 18 cancer types tested, making tumor–normal expression one of SNRPGP14’s most consistent transcriptional readouts.

The strongest signal is observed in colon adenocarcinoma (COAD), where SNRPGP14 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types SNRPGP14 is over-expressed in tumor, although a few such as BRCA show the opposite, repressed pattern.

COAD, KICH, and LIHC are the cancer types where SNRPGP14 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in SNRPGP14 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
COAD	Male	II,III,IV	+0.695	.003	8	view →
KICH	All	II,III,IV	+0.641	.001	7	view →
LIHC	All	All	+0.209	.004	5	view →
CHOL	Male	All	+1.010	.005	2	view →
BLCA	All	All	+0.447	.041	2	view →
HNSC	Male	II,III,IV	+0.197	.017	2	view →
STAD	All	II,III,IV	+0.340	.031	1	view →
BRCA	All	All	−0.194	.042	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 8 strongest of 8 lineages.

SNRPGP14–COAD

Open the COAD breakdown →